The effects of systemic medications on ocular blood flow

Canadian Journal of Ophthalmology

Volumn 43, Issue 3, 2008, Pages 351-355

  Lesk, Mark R ^a,c   Wajszilber, Marcelo ^b   Deschenes, Micheline C ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Estrogens; Glaucoma; Nitric oxide; Ocular blood flow; Optic nerve head; Systemic blood pressure

Indexed keywords

ADENOSINE; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DOPAMINE; DROPERIDOL; ENDOTHELIN 1; ESTROGEN; FLUNARIZINE; GINKGO BILOBA EXTRACT; HISTAMINE; INDOMETACIN; KETANSERIN; LOMERIZINE; LOSARTAN; NIFEDIPINE; NILVADIPINE; NIMODIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SILDENAFIL; TRANDOLAPRIL; DRUG;

BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECT; EYE BLOOD FLOW; GLAUCOMA; HUMAN; OCULAR BLOOD VESSEL; OPTIC NERVE; REVIEW; BLOOD FLOW; BLOOD FLOW VELOCITY; EYE; OPEN ANGLE GLAUCOMA; OPTIC DISK; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; VASCULARIZATION;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; EYE; GLAUCOMA, OPEN-ANGLE; HUMANS; OPTIC DISK; PHARMACEUTICAL PREPARATIONS; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 47549100599     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I08-057     Document Type: Review

References (55)

1. Cioffi GA, Granstam E, Alm A. Ocular circulation. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye. 10th ed. St. Louis, Mo.: Mosby; 2003;747-84.
2. Hafez AS, Bizzarro RL, Rivard M, Lesk MR Changes in optic nerve head blood flow after therapeutic intraocular pressure reduction in glaucoma patients and ocular hypertensives. Ophthalmology 2003;110:201-10.
3. Costa VP, Harris A, Stefánsson E, et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 2003;22:769-805.
4. Luksch A, Rainer G, Koyuncu D, et al. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol 2005;89:21-5.
5. Polak K, Luksch A, Berisha F, Fuchsjaeger-Mayrl G, Dallinger S, Schmetterer L. Altered nitric oxide system in patients with open-angle glaucoma. Arch Ophthalmol 2007;125:494-8.
6. Michalk F, Michelson G, Harazny J, Werner U, Daniel WG, Werner D. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma 2004;13:158-62.
7. Harris A, Evans DW, Cantor LB, Martin B. Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol 1997;124: 296-302.
8. Wilson RP, Chang WJ, Sergott RC, et al. A color Doppler analysis of nifedipine-induced posterior ocular blood flow changes in open-angle glaucoma. J Glaucoma 1997;6:231-6.
9. Geyer O, Neudorfer M, Kessler A, Firsteter E, Lazar M, Almog Y. Effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma. Br J Ophthalmol 1996;80:1060-2.
10. Schmidt KG, Mittag TW, Pavlovic S, Hessemer V. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol 1996;234:527-32.
11. Rainer G, Kiss B, Dallinger S, et al. A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma. Br J Clin Pharmacol 2001;52:210-2.
12. Yamamoto T, Niwa Y, Kawakami H, Kitazawa Y. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma 1998;7:301-5.
13. Niwa Y, Yamamoto T, Harris A, Kagemann L, Kawakami H, Kitazawa Y. Relationship between the effect of carbon dioxide inhalation or nilvadipine on orbital blood flow in normal-tension glaucoma. J Glaucoma 2000;9:262-7.
14. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma 1998;7:336-42.
15. Cellini M, Possati GL, Caramazza N, Profazio V, Caramazza R. The use of flunarizine in the management of low-tension glaucoma: a color Doppler study. Acta Ophthalmol Scand Suppl 1997;(224):57-8.
16. Tamaki Y, Araie M, Fukaya Y, et al. Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans. Invest Ophthalmol Vis Sci 2003;44:4864-71.
17. Steigerwalt RD Jr, Belcaro GV, Laurora G, Cesarone MR, De Sanctis MT, Incandela L. Ocular and orbital blood flow in patients with essential hypertension treated with trandolapril. Retina 1998;18:539-45.
18. Matulla B, Streit G, Pieh S, et al. Effects of losartan on cerebral and ocular circulation in healthy subjects. Br J Clin Pharmacol 1997;44:369-75.
19. Spicher T, Orgül S, Gugleta K, Teuchner B, Flammer J. The effect of losartan potassium on choroidal hemodynamics in healthy subjects. J Glaucoma 2002;11:177-82.
20. Weigert G, Resch H, Luksch A, et al. Intavenous administration of clonidine reduces intraocular pressure and alters ocular blood flow. Br J Ophthalmol 2007;91:1354-8.
21. Huemer KH, Zawinka C, Garhöfer G, et al. Effect of dopamine on retinal and choroidal blood flow parameters in humans. Br J Ophthalmol 2007;91:1194-8.
22. Harris A, Zalish M, Kagemann L, Siesky B, Migliardi R, Garzozi HJ. Effect of intravenous droperidol on intraocular pressure and retrobulbar hemodynamics. Eur J Ophthalmol 2002;12:193-9.
23. Zawinka C, Resch H, Schmetterer L, Dorner GT, Garhofer G. Intravenously administered histamine increases choroidal but not retinal blood flow. Invest Ophthalmol Vis Sci 2004;45:2337-41.
24. Resch H, Zaminka C, Lung S, Weigert G, Schmetterer L, Garhöfer G. Effect of histamine and cimetidine on retinal and choroidal blood flow in humans. Am J Physiol Regul Integr Comp Physiol 2005;289:R1387-91.
25. Weigert G, Zawinka C, Resch H, Schmetterer L, Garhöfer G. Intravenous administration of diphenhydramine reduces histamine-induced vasodilator effects in retina and choroid. Invest Ophthalmol Vis Sci 2006;47:1096-100.
26. Cellini M, Caramazza R. Color doppler imaging of ocular blood flow after topical ketanserin. Ophthalmologica 1999;213:286-9.
27. Polak K, Wimpissinger B, Berisha F, Georgopoulos M, Schmetterer L. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Invest Ophthalmol Vis Sci 2003;44:4872-6.
28. Garhöfer G, Resch H, Lung S, Weigert G, Schmetterer L. Intravenous administration of L-arginine increases retinal and choroidal blood flow. Am J Ophthalmol 2005;140:69-76.
29. Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 2003;76:633-40.
30. Polska E, Ehrlich P, Luksch A, Fuchsjäger-Mayrl G, Schmetterer L. Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans. Invest Ophthalmol Vis Sci 2003;44:3110-4.
31. Weigert G, Berisha F, Resch H, Karl K, Schmetterer L, Garhofer G. Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow. Invest Ophthalmol Vis Sci 2008;49:1065-70.
32. Deschênes MC, Moreau M, Granger L, et al. Hormone replacement therapy in menopausal women: effects on the retinal arterial blood flow and optic nerve head topography. Invest Ophthalmol Vis Sci 2005;46:E-abstract 3928.
33. Harris-Yitzhak M, Harris A, Ben-Refael Z, Zarfati D, Garzozi HJ, Martin BJ. Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 2000; 129:623-8.
34. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172:1273-8.
35. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 1999;15:233-40.
36. Wimpissinger B, Berisha F, Garhoefer G, Polak K, Schmetterer L. Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol Scand 2007;85:445-9. Epub 2007 Feb 27.
37. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-21.
38. Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure and the systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102:54-60.
39. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-93.
40. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B; BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008;115:85-93.
41. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-72.
42. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmohgy 1995;102:61-9.
43. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Noctural arterial hypotension and its role in optic nerve and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-24.
44. Gherghel D, Orgül S, Gugleta K, Flammer J. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol 2001;132:641-7.
45. Choi J, Kim KH, Jeong J, Cho HS, Lee CH, Kook MS. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci 2007;48:104-11.
46. Fuchsjäger-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004;45:834-9.
47. Grunwald JE, Piltz J, Hariprasad SM, Dupont J, Maguire MG. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol 1999;127:516-22.
48. Jeanson P, Descovich D, Hafez A, et al. Effect of treating systemic hypertension on optic nerve head and retinal blood flow. Invest Ophthalmol Vis Sci 2005;46:E-abstract 1333.
49. Hulsman CA, Westendorp IC, Ramrattan RS, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001;154:138-44.
50. Drance S, Anderson DR, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001;131:699-708.
51. Slopień R, Junik R, Meczekalski B, et al. Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas 2003;46:255-62.
52. Lee SJ, McEwen BS. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 2001;41:569-91.
53. Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007;26:205-38.
54. Huemer KH, Garhofer G, Aggermann T, Kolodjaschna J, Schmetterer L, Fuchsjäger-Mayrl G. Role of nitric oxide in choroidal blood flow regulation during light/dark transitions. Invest Ophthalmol Vis Sci 2007;48:4215-9.
55. Ritch, R. Natural Compounds: evidence for a protective role in eye disease. Can J Ophthalmol 2007;42:425-38.